February 13, 2017 10:40 AM ESTUpdated 11:18 AM

On a shopping spree, Allergan bags CoolSculpting tech in $2.5B buyout; Akebia strikes research deal with J&J

Shehla Shakoor

Managing Director

• Botox-maker Allergan has bagged a new company for its medical aesthetics portfolio, paying $2.47 billion for Pleasanton, CA-based Zeltiq Aesthetics $ZLTQ. Zeltiq made …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

On a shopping spree, Allergan bags CoolSculpting tech in $2.5B buyout; Akebia strikes research deal with J&J

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

On a shop­ping spree, Al­ler­gan bags CoolSculpt­ing tech in $2.5B buy­out; Ake­bia strikes re­search deal with J&J

Managing Director

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

On a shopping spree, Allergan bags CoolSculpting tech in $2.5B buyout; Akebia strikes research deal with J&J